Yxol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yxol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yxol Today - Breaking & Trending Today

Ocuphire Presenting New Data and Updates on APX3330 and Nyxol® Clinical Programs at Virtual Investor R&D Day

New data support Phase 3 development of Nyxol alone as a durable single eye drop for the potential treatment of Presbyopia First update on recruitment in APX3330 ZETA-1 Phase 2b trial: ~70% patients. | January 31, 2022 ....

David Boyer , James Katz , Kols Jay Pepose , Bindu Manne , Mina Sooch , Mitchell Jackson , Peter Kaiser , Kolspaul Karpecki , Corey Davis , Kols Mark Kelley , Ocuphire Pharma , Head Of Market Development , Ocuphire Pharma Inc , Investor Rd Day , Key Opinion Leaders , Diabetic Retinopathy , Mark Kelley , Paul Karpecki , Market Development , Jay Pepose , New Drug Applications , Anticipated Milestones , Nyxol Phase , Vision Disturbances , Diabetic Macular Edema , Private Securities Litigation Reform Act ,